• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

三阴性乳腺癌的临床特征:一个亚洲发展中国家的经验

Clinical characteristics of triple-negative breast cancer: experience in an Asian developing country.

作者信息

Tan G H, Taib Nur Aishah, Choo W Y, Teo S H, Yip Cheng Har

机构信息

Dept of Surgery, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.

出版信息

Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):395-8.

PMID:19640180
Abstract

INTRODUCTION

Triple negative (TN) breast cancers are defined by a lack of expression of oestrogen, progesterone, and HER2 receptors. They tend to have a higher grade, with a poorer outcome compared to non-TN breast cancers.

OBJECTIVE

The aim of this study is to determine the incidence of TN breast cancer in an Asian country consisting of Malays, Chinese and Indians, and to determine the factors associated with this type of breast cancer.

RESULTS

The incidence of TN breast cancer in the University Malaya Medical Center is 17.6%. There is no significant difference amongst the Malays, Chinese and Indians. In bivariate analysis, TN breast cancer was significantly associated with younger age and Grade 3. However, in multivariate analysis using logistic regression, TN breast cancer was only associated with Grade 3.

CONCLUSION

The incidence of TN breast cancer in our study is similar to other studies, and associated with a higher grade.

摘要

引言

三阴性(TN)乳腺癌的定义是缺乏雌激素、孕激素和HER2受体的表达。与非TN乳腺癌相比,它们往往分级更高,预后更差。

目的

本研究的目的是确定一个由马来人、华人及印度人组成的亚洲国家中TN乳腺癌的发病率,并确定与这类乳腺癌相关的因素。

结果

马来亚大学医学中心TN乳腺癌的发病率为17.6%。马来人、华人及印度人之间无显著差异。在双变量分析中,TN乳腺癌与较年轻年龄及3级显著相关。然而,在使用逻辑回归的多变量分析中,TN乳腺癌仅与3级相关。

结论

我们研究中TN乳腺癌的发病率与其他研究相似,且与更高分级相关。

相似文献

1
Clinical characteristics of triple-negative breast cancer: experience in an Asian developing country.三阴性乳腺癌的临床特征:一个亚洲发展中国家的经验
Asian Pac J Cancer Prev. 2009 Jul-Sep;10(3):395-8.
2
Factors associated with HER2 overexpression in breast cancer: Experience in an Asian developing country.乳腺癌中与HER2过表达相关的因素:一个亚洲发展中国家的经验
Asian Pac J Cancer Prev. 2009;10(5):837-40.
3
Distribution of molecular breast cancer subtypes among Algerian women and correlation with clinical and tumor characteristics: a population-based study.阿尔及利亚女性分子乳腺癌亚型的分布及其与临床和肿瘤特征的相关性:一项基于人群的研究。
Breast Dis. 2015;35(2):95-102. doi: 10.3233/BD-150398.
4
Triple-negative breast cancers: unique clinical presentations and outcomes.三阴性乳腺癌:独特的临床表现和结局。
Ann Surg Oncol. 2010 Oct;17 Suppl 3:384-90. doi: 10.1245/s10434-010-1260-4. Epub 2010 Sep 19.
5
Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma.三阴性乳腺癌中的大汗腺癌:大汗腺型浸润性导管癌为雌激素/孕激素受体阴性、雄激素受体阳性的新型定义。
Jpn J Clin Oncol. 2012 May;42(5):375-86. doi: 10.1093/jjco/hys034. Epub 2012 Mar 26.
6
[Analysis of clinicopathological characteristics and prognosis for triple negative breast cancer: a report of 108 cases].三阴性乳腺癌的临床病理特征及预后分析:附108例报告
Zhonghua Zhong Liu Za Zhi. 2008 Mar;30(3):196-9.
7
Estrogen receptor, progesterone receptor, and HER2 status predict lymphovascular invasion and lymph node involvement.雌激素受体、孕激素受体和人表皮生长因子受体2状态可预测淋巴管侵犯和淋巴结受累情况。
Ann Surg Oncol. 2014 Nov;21(12):3780-6. doi: 10.1245/s10434-014-3851-y. Epub 2014 Jun 21.
8
Breast Cancer Molecular Subtypes Defined by ER/PR and HER2 Status: Association with Clinicopathologic Parameters in Ivorian Patients.由雌激素受体/孕激素受体(ER/PR)和人表皮生长因子受体2(HER2)状态定义的乳腺癌分子亚型:与科特迪瓦患者临床病理参数的相关性
Asian Pac J Cancer Prev. 2016;17(4):1973-8. doi: 10.7314/apjcp.2016.17.4.1973.
9
High incidence and frequency of LOH are associated with aggressive features of high-grade HER2 and triple-negative breast cancers.高发生率和高频率的 LOH 与高级别 HER2 和三阴性乳腺癌的侵袭性特征相关。
Breast Cancer. 2012 Apr;19(2):161-9. doi: 10.1007/s12282-010-0232-7. Epub 2010 Nov 10.
10
Is triple negative a prognostic factor in breast cancer?三阴性是乳腺癌的一个预后因素吗?
Breast Cancer. 2008;15(4):303-8. doi: 10.1007/s12282-008-0042-3. Epub 2008 Mar 29.

引用本文的文献

1
A Novel Subset of Triple-Negative Breast Cancers with Unique Histology and Immunohistochemical Expression.一种具有独特组织学和免疫组化表达的三阴性乳腺癌新亚型。
Iran J Pathol. 2022 Spring;17(2):217-224. doi: 10.30699/IJP.2022.139734.2526. Epub 2022 Mar 8.
2
Down Regulated Expression Levels of miR-27b and miR-451a as a Potential Biomarker for Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy.miR-27b 和 miR-451a 的下调表达水平可作为接受 TAC 化疗的三阴性乳腺癌患者的潜在生物标志物。
Asian Pac J Cancer Prev. 2022 Mar 1;23(3):1053-1059. doi: 10.31557/APJCP.2022.23.3.1053.
3
Regulation of Cellular and Cancer Stem Cell-Related Putative Gene Expression of Parental and CD44CD24 Sorted MDA-MB-231 Cells by Cisplatin.
顺铂对亲本及CD44CD24分选的MDA-MB-231细胞中细胞及癌症干细胞相关假定基因表达的调控
Pharmaceuticals (Basel). 2021 Apr 21;14(5):391. doi: 10.3390/ph14050391.
4
The Association of Tumor-Infiltrating Lymphocytes and Programmed Cell Death 1 Expression with the Incidence of Distant Metastasis in Triple-Negative Breast Cancer Subjects in Sanglah General Hospital, Bali, Indonesia.印度尼西亚巴厘岛桑格拉总医院三阴性乳腺癌患者肿瘤浸润淋巴细胞及程序性细胞死亡蛋白1表达与远处转移发生率的相关性
Case Rep Oncol. 2021 Mar 8;14(1):347-351. doi: 10.1159/000514272. eCollection 2021 Jan-Apr.
5
Clinicopathological and Prognostic Characteristics of Malaysian Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy Regimen.接受TAC化疗方案的马来西亚三阴性乳腺癌患者的临床病理特征及预后特征
Int J Breast Cancer. 2020 Apr 1;2020:8424365. doi: 10.1155/2020/8424365. eCollection 2020.
6
Clinical Characteristics in Patients with Triple Negative Breast Cancer.三阴性乳腺癌患者的临床特征
Int J Breast Cancer. 2017;2017:1796145. doi: 10.1155/2017/1796145. Epub 2017 Aug 17.
7
Increased Tumour Infiltration of CD4+ and CD8+ T-Lymphocytes in Patients with Triple Negative Breast Cancer Suggests Susceptibility to Immune Therapy.三阴性乳腺癌患者中CD4+和CD8+ T淋巴细胞的肿瘤浸润增加提示对免疫治疗敏感。
Asian Pac J Cancer Prev. 2017 Jul 27;18(7):1827-1832. doi: 10.22034/APJCP.2017.18.7.1827.
8
Breast Cancer Outcomes as Defined by the Estrogen Receptor, Progesterone Receptor, and Human Growth Factor Receptor-2 in a Multi-ethnic Asian Country.在一个多民族亚洲国家中,由雌激素受体、孕激素受体和人类生长因子受体-2所定义的乳腺癌预后情况。
World J Surg. 2015 Oct;39(10):2450-8. doi: 10.1007/s00268-015-3133-2.
9
Correlation of CK5 and EGFR with Clinicopathological Profile of Triple-Negative Breast Cancer.CK5和EGFR与三阴性乳腺癌临床病理特征的相关性
Patholog Res Int. 2014;2014:141864. doi: 10.1155/2014/141864. Epub 2014 Oct 23.
10
Immunohistochemical profile and morphology in triple - negative breast cancers.三阴性乳腺癌的免疫组化特征及形态学
J Clin Diagn Res. 2013 Jul;7(7):1361-5. doi: 10.7860/JCDR/2013/5823.3129. Epub 2013 May 28.